Publication:
Effects of Recombinant Activated Protein C Derived From Drotrecogin-Alpha on Bleomycin-Induced Pulmonary Fibrosis in Rats Compared with Methyl-Prednisolone

No Thumbnail Available
Date
2013-04-01T00:00:00Z
Authors
Authors
Yildiz, Kadir
Iraz, Mustafa
ŞAMDANCI, EMİNE
ÖZEROL, ELİF
KUKU, İRFAN
AYTEMUR, ZEYNEP AYFER
HACIEVLİYAGİL, SÜLEYMAN SAVAŞ
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue

Metrics

Search on Google Scholar

Abstract
OBJECTIVE: In this study, we aimed to test the preventive effects of intraperitoneally administered drotrecogin alpha which is derived from activated protein C (APC), on bleomycin-induced pulmonary fibrosis in rats, and to compare the effects of APC with the effects of methyl-prednisolone, a traditional therapy.
Description
Keywords
Citation
Yildiz K., Iraz M., ŞAMDANCI E., ÖZEROL E., KUKU İ., AYTEMUR Z. A. , HACIEVLİYAGİL S. S. , -Effects of Recombinant Activated Protein C Derived From Drotrecogin-Alpha on Bleomycin-Induced Pulmonary Fibrosis in Rats Compared with Methyl-Prednisolone-, TURKISH THORACIC JOURNAL, cilt.14, ss.48-52, 2013
Page Views

0

File Downloads

0

Sustainable Development Goals